{"title":"skinage XAI:一个可解释的皮肤病变诊断深度学习解决方案。","authors":"Geetika Munjal, Paarth Bhardwaj, Vaibhav Bhargava, Shivendra Singh, Nimish Nagpal","doi":"10.1002/hcs2.121","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Skin cancer poses a significant global health threat, with early detection being essential for successful treatment. While deep learning algorithms have greatly enhanced the categorization of skin lesions, the black-box nature of many models limits interpretability, posing challenges for dermatologists.</p><p><strong>Methods: </strong>To address these limitations, SkinSage XAI utilizes advanced explainable artificial intelligence (XAI) techniques for skin lesion categorization. A data set of around 50,000 images from the Customized HAM10000, selected for diversity, serves as the foundation. The Inception v3 model is used for classification, supported by gradient-weighted class activation mapping and local interpretable model-agnostic explanations algorithms, which provide clear visual explanations for model outputs.</p><p><strong>Results: </strong>SkinSage XAI demonstrated high performance, accurately categorizing seven types of skin lesions-dermatofibroma, benign keratosis, melanocytic nevus, vascular lesion, actinic keratosis, basal cell carcinoma, and melanoma. It achieved an accuracy of 96%, with precision at 96.42%, recall at 96.28%, <i>f</i> <sub>1</sub> score at 96.14%, and an area under the curve of 99.83%.</p><p><strong>Conclusions: </strong>SkinSage XAI represents a significant advancement in dermatology and artificial intelligence by bridging gaps in accuracy and explainability. The system provides transparent, accurate diagnoses, improving decision-making for dermatologists and potentially enhancing patient outcomes.</p>","PeriodicalId":100601,"journal":{"name":"Health Care Science","volume":"3 6","pages":"438-455"},"PeriodicalIF":0.0000,"publicationDate":"2024-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11671215/pdf/","citationCount":"0","resultStr":"{\"title\":\"SkinSage XAI: An explainable deep learning solution for skin lesion diagnosis.\",\"authors\":\"Geetika Munjal, Paarth Bhardwaj, Vaibhav Bhargava, Shivendra Singh, Nimish Nagpal\",\"doi\":\"10.1002/hcs2.121\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Skin cancer poses a significant global health threat, with early detection being essential for successful treatment. While deep learning algorithms have greatly enhanced the categorization of skin lesions, the black-box nature of many models limits interpretability, posing challenges for dermatologists.</p><p><strong>Methods: </strong>To address these limitations, SkinSage XAI utilizes advanced explainable artificial intelligence (XAI) techniques for skin lesion categorization. A data set of around 50,000 images from the Customized HAM10000, selected for diversity, serves as the foundation. The Inception v3 model is used for classification, supported by gradient-weighted class activation mapping and local interpretable model-agnostic explanations algorithms, which provide clear visual explanations for model outputs.</p><p><strong>Results: </strong>SkinSage XAI demonstrated high performance, accurately categorizing seven types of skin lesions-dermatofibroma, benign keratosis, melanocytic nevus, vascular lesion, actinic keratosis, basal cell carcinoma, and melanoma. It achieved an accuracy of 96%, with precision at 96.42%, recall at 96.28%, <i>f</i> <sub>1</sub> score at 96.14%, and an area under the curve of 99.83%.</p><p><strong>Conclusions: </strong>SkinSage XAI represents a significant advancement in dermatology and artificial intelligence by bridging gaps in accuracy and explainability. The system provides transparent, accurate diagnoses, improving decision-making for dermatologists and potentially enhancing patient outcomes.</p>\",\"PeriodicalId\":100601,\"journal\":{\"name\":\"Health Care Science\",\"volume\":\"3 6\",\"pages\":\"438-455\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-11-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11671215/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Health Care Science\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1002/hcs2.121\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/12/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Health Care Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/hcs2.121","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
SkinSage XAI: An explainable deep learning solution for skin lesion diagnosis.
Background: Skin cancer poses a significant global health threat, with early detection being essential for successful treatment. While deep learning algorithms have greatly enhanced the categorization of skin lesions, the black-box nature of many models limits interpretability, posing challenges for dermatologists.
Methods: To address these limitations, SkinSage XAI utilizes advanced explainable artificial intelligence (XAI) techniques for skin lesion categorization. A data set of around 50,000 images from the Customized HAM10000, selected for diversity, serves as the foundation. The Inception v3 model is used for classification, supported by gradient-weighted class activation mapping and local interpretable model-agnostic explanations algorithms, which provide clear visual explanations for model outputs.
Results: SkinSage XAI demonstrated high performance, accurately categorizing seven types of skin lesions-dermatofibroma, benign keratosis, melanocytic nevus, vascular lesion, actinic keratosis, basal cell carcinoma, and melanoma. It achieved an accuracy of 96%, with precision at 96.42%, recall at 96.28%, f1 score at 96.14%, and an area under the curve of 99.83%.
Conclusions: SkinSage XAI represents a significant advancement in dermatology and artificial intelligence by bridging gaps in accuracy and explainability. The system provides transparent, accurate diagnoses, improving decision-making for dermatologists and potentially enhancing patient outcomes.